Cerebral venous sinus thrombosis natural history: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (13 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Cerebral venous sinus thrombosis}} | {{Cerebral venous sinus thrombosis}} | ||
{{CMG}} {{AE}} {{ SharmiB}} | |||
==Overview== | |||
Common complications of [[cerebral venous thrombosis]] include [[neurological]] deficits, [[coma]], and death. | |||
==Natural History, Complications, and Prognosis== | |||
===Natural History=== | |||
*The symptoms of [[cerebral venous thrombosis]](CVT) usually develop in the first decade of life, and start with [[symptoms]] such as [[headache]], [[seizures]], [[neurological]] deficits, [[visual]] [[impairment]], decreased level of [[consciousness]]. <ref name="BushnellSaposnik2014">{{cite journal|last1=Bushnell|first1=Cheryl|last2=Saposnik|first2=Gustavo|title=Evaluation and Management of Cerebral Venous Thrombosis|journal=CONTINUUM: Lifelong Learning in Neurology|volume=20|year=2014|pages=335–351|issn=1080-2371|doi=10.1212/01.CON.0000446105.67173.a8}}</ref><ref name="FaizVetvik2018">{{cite journal|last1=Faiz|first1=Kashif Waqar|last2=Vetvik|first2=Kjersti Grøtta|last3=Harper|first3=Charlotte Elena|last4=Kristoffersen|first4=Espen Saxhaug|title=Cerebral venetrombose – forekomst, diagnostikk og behandling|journal=Tidsskrift for Den norske legeforening|year=2018|issn=0029-2001|doi=10.4045/tidsskr.17.1047}}</ref> | |||
* 15% of patients with CVT may progress to develop residual [[epilepsy]], [[cognitive]] impairment, recurrent CVT or systemic [[thromboembolism]]. | |||
===Complications=== | |||
*Common [[complications]] of [[cerebral venous thrombosis]] (CVT) include: | |||
** [[Hydrocephalus]]<ref name="FaizVetvik2018">{{cite journal|last1=Faiz|first1=Kashif Waqar|last2=Vetvik|first2=Kjersti Grøtta|last3=Harper|first3=Charlotte Elena|last4=Kristoffersen|first4=Espen Saxhaug|title=Cerebral venetrombose – forekomst, diagnostikk og behandling|journal=Tidsskrift for Den norske legeforening|year=2018|issn=0029-2001|doi=10.4045/tidsskr.17.1047}}</ref><ref name="BushnellSaposnik2014">{{cite journal|last1=Bushnell|first1=Cheryl|last2=Saposnik|first2=Gustavo|title=Evaluation and Management of Cerebral Venous Thrombosis|journal=CONTINUUM: Lifelong Learning in Neurology|volume=20|year=2014|pages=335–351|issn=1080-2371|doi=10.1212/01.CON.0000446105.67173.a8}}</ref> | |||
** [[Cognitive impairment]] | |||
** [[Neurological]] deficit | |||
** Residual [[epilepsy]] | |||
** [[Coma]] | |||
** Death | |||
===Prognosis=== | |||
The [[prognosis]] of CVT is favorable than other [[strokes]]. Complete functional [[recovery]] has been reported in 75% of [[patients]] but 15% of [[patients]] die or become dependent.<ref name="FerroCanhão2004">{{cite journal|last1=Ferro|first1=José M.|last2=Canhão|first2=Patrícia|last3=Stam|first3=Jan|last4=Bousser|first4=Marie-Germaine|last5=Barinagarrementeria|first5=Fernando|title=Prognosis of Cerebral Vein and Dural Sinus Thrombosis|journal=Stroke|volume=35|issue=3|year=2004|pages=664–670|issn=0039-2499|doi=10.1161/01.STR.0000117571.76197.26}}</ref> Study showed women has better [[prognosis]] than men. 81% of women recovered completely while only 71 % of men had so.<ref name="CoutinhoFerro2009">{{cite journal|last1=Coutinho|first1=Jonathan M.|last2=Ferro|first2=José M.|last3=Canhão|first3=Patrícia|last4=Barinagarrementeria|first4=Fernando|last5=Cantú|first5=Carlos|last6=Bousser|first6=Marie-Germaine|last7=Stam|first7=Jan|title=Cerebral Venous and Sinus Thrombosis in Women|journal=Stroke|volume=40|issue=7|year=2009|pages=2356–2361|issn=0039-2499|doi=10.1161/STROKEAHA.108.543884}}</ref> Recurrent [[thrombosis]] is a common complication in CVT, around 6.5% per year but mostly in [[patients]] who are not on [[anticoagualnts]].<ref name="FerroCanhão2004">{{cite journal|last1=Ferro|first1=José M.|last2=Canhão|first2=Patrícia|last3=Stam|first3=Jan|last4=Bousser|first4=Marie-Germaine|last5=Barinagarrementeria|first5=Fernando|title=Prognosis of Cerebral Vein and Dural Sinus Thrombosis|journal=Stroke|volume=35|issue=3|year=2004|pages=664–670|issn=0039-2499|doi=10.1161/01.STR.0000117571.76197.26}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Neurology]] | |||
[[Category:Disease]] | |||
Latest revision as of 22:08, 25 July 2021
|
Cerebral venous sinus thrombosis Microchapters |
|
Differentiating Cerebral venous sinus thrombosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cerebral venous sinus thrombosis natural history On the Web |
|
American Roentgen Ray Society Images of Cerebral venous sinus thrombosis natural history |
|
Cerebral venous sinus thrombosis natural history in the news |
|
Directions to Hospitals Treating Cerebral venous sinus thrombosis |
|
Risk calculators and risk factors for Cerebral venous sinus thrombosis natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sharmi Biswas, M.B.B.S
Overview
Common complications of cerebral venous thrombosis include neurological deficits, coma, and death.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of cerebral venous thrombosis(CVT) usually develop in the first decade of life, and start with symptoms such as headache, seizures, neurological deficits, visual impairment, decreased level of consciousness. [1][2]
- 15% of patients with CVT may progress to develop residual epilepsy, cognitive impairment, recurrent CVT or systemic thromboembolism.
Complications
- Common complications of cerebral venous thrombosis (CVT) include:
- Hydrocephalus[2][1]
- Cognitive impairment
- Neurological deficit
- Residual epilepsy
- Coma
- Death
Prognosis
The prognosis of CVT is favorable than other strokes. Complete functional recovery has been reported in 75% of patients but 15% of patients die or become dependent.[3] Study showed women has better prognosis than men. 81% of women recovered completely while only 71 % of men had so.[4] Recurrent thrombosis is a common complication in CVT, around 6.5% per year but mostly in patients who are not on anticoagualnts.[3]
References
- ↑ 1.0 1.1 Bushnell, Cheryl; Saposnik, Gustavo (2014). "Evaluation and Management of Cerebral Venous Thrombosis". CONTINUUM: Lifelong Learning in Neurology. 20: 335–351. doi:10.1212/01.CON.0000446105.67173.a8. ISSN 1080-2371.
- ↑ 2.0 2.1 Faiz, Kashif Waqar; Vetvik, Kjersti Grøtta; Harper, Charlotte Elena; Kristoffersen, Espen Saxhaug (2018). "Cerebral venetrombose – forekomst, diagnostikk og behandling". Tidsskrift for Den norske legeforening. doi:10.4045/tidsskr.17.1047. ISSN 0029-2001.
- ↑ 3.0 3.1 Ferro, José M.; Canhão, Patrícia; Stam, Jan; Bousser, Marie-Germaine; Barinagarrementeria, Fernando (2004). "Prognosis of Cerebral Vein and Dural Sinus Thrombosis". Stroke. 35 (3): 664–670. doi:10.1161/01.STR.0000117571.76197.26. ISSN 0039-2499.
- ↑ Coutinho, Jonathan M.; Ferro, José M.; Canhão, Patrícia; Barinagarrementeria, Fernando; Cantú, Carlos; Bousser, Marie-Germaine; Stam, Jan (2009). "Cerebral Venous and Sinus Thrombosis in Women". Stroke. 40 (7): 2356–2361. doi:10.1161/STROKEAHA.108.543884. ISSN 0039-2499.